| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 69.943 | 70.693 | 71.322 | 88.768 | 93.153 | 101.407 | 84.349 | 93.697 | 120.512 | 149.867 |
| Total Income - EUR | 71.469 | 81.520 | 75.067 | 93.462 | 97.086 | 112.501 | 87.807 | 97.481 | 124.285 | 153.883 |
| Total Expenses - EUR | 50.983 | 71.631 | 68.229 | 71.507 | 74.353 | 85.973 | 77.141 | 91.187 | 88.079 | 92.694 |
| Gross Profit/Loss - EUR | 20.486 | 9.889 | 6.839 | 21.954 | 22.733 | 26.528 | 10.666 | 6.294 | 36.206 | 61.189 |
| Net Profit/Loss - EUR | 17.290 | 9.073 | 4.555 | 21.060 | 21.802 | 25.726 | 9.836 | 5.357 | 35.146 | 57.360 |
| Employees | 6 | 6 | 6 | 6 | 7 | 6 | 6 | 6 | 6 | 6 |
Check the financial reports for the company - Anasan Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 57.069 | 68.189 | 54.227 | 41.492 | 28.359 | 16.823 | 11.743 | 18.654 | 17.877 | 64.047 |
| Current Assets | 225.438 | 158.176 | 122.514 | 92.663 | 50.847 | 63.575 | 61.608 | 59.055 | 56.644 | 103.448 |
| Inventories | 4.757 | 2.435 | 4.276 | 5.818 | 6.667 | 8.424 | 12.036 | 12.656 | 6.109 | 5.047 |
| Receivables | 213.407 | 153.167 | 117.910 | 83.219 | 30.931 | 44.060 | 40.526 | 40.861 | 43.437 | 44.267 |
| Cash | 7.273 | 2.575 | 329 | 3.626 | 13.249 | 11.091 | 9.046 | 5.537 | 7.098 | 54.134 |
| Shareholders Funds | 232.079 | 161.071 | 123.934 | 93.295 | 50.070 | 12.826 | 22.176 | 7.324 | 42.448 | 97.560 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 50.428 | 34.000 | 25.786 | 18.345 | 10.989 | 53.626 | 40.997 | 63.959 | 29.439 | 69.935 |
| Income in Advance | 0 | 31.295 | 27.021 | 22.515 | 18.147 | 13.945 | 10.178 | 6.426 | 2.634 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Anasan Med S.r.l.